Often, cross-talk between B1R and B2R with epidermal growth factor receptor (EGFR) receptors, either via intracellular transactivation or by extracellular shedding of HER ligands, maintains tumor growth, as reported in glioblastoma (GBM) [9]. Here, BDKRB1 is linked to neoplasm.